Furthermore, GTN inhibited metastasized breast cancer cells (in the detachment model) by inducing anoikis via decreased MMP secretion, a reversal of the EMT proteins, and attenuated EGFR/FAK/Src survival pathways. The gene discussed is PTK2; the disease is breast carcinoma.